Live Interview with Cheddar (1/4/2020):  Niven dives into BERG’s two potential drug products moving towards Phase III development and other late stage assets in planning phases, the future of AI within discovery, and partnering with big pharma companies to improve patient outcomes.  Click HERE for the interview.

BERG is pleased to share the Financial Times feature by Global Pharmaceuticals Editor, Sarah Neville, “Why big pharma sees a remedy in data and AI”, that  includes commentary from Dr. Niven R. Narain, President and CEO of BERG along with notable leaders from the likes of Novartis, Pfizer and Flatiron Health. The article highlights the…

By Michael Fitzhugh For anyone not hip-deep in the hot field of artificial intelligence (AI), its role in drug discovery — or in any endeavor, for that matter — can feel vague, especially relative to the concrete problems drugmakers face daily. The very definition of AI can seem fuzzy, touted at times as capable of…

  In a bad year, only a small percentage of people vaccinated against the flu are actually protected. But now researchers are using AI and computer models to change that. Reporter Matt Reynolds highlights BERG’s commitment to using individual patient biologies to develop vaccines that are more specific and effective, citing BERG’s ongoing partnership with…

This Financial Times article highlights some of BERG’s key partnerships and position as a leader in the application of machine learning and AI in drug discovery. Particularly, the piece highlights BERG as one of the leading companies looking to identify and eliminate inefficiencies and reform the traditional trial and error drug discovery process.   To read the…

This Forbes article was written following a lecture Dr. Niven R. Narain, Ph.D., BERG Co-Founder, President and CEO, gave at Harvard Medical School during the AI Applications Summit for BioPharma in October. The conference provided a useful snapshot into what is happening at the intersection of AI and life sciences and the article describes the author’s ten…